智通财经APP讯,振东制药(300158.SZ)发布公告,近日,公司收到控股股东振东集团出具的《股份减持计划实施进展的告知函》。截至本公告日,振东集团本次减持计划减持时间已过半,其减持公司股份1998.4万股,占公司总股本比例1.9449%。
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.